Johnson & Johnson confirms Covid-19 vaccine trial paused on safety event

News of the halt comes after AstraZeneca Plc temporarily stopped tests of its vaccine after a trial participant fell ill. That study has resumed in a number of countries but remains halted in the US.

Updated on: Oct 13, 2020, 07:14:28 IST

By Anonymous

Prefer HTon Google

Share via

Copy link

Johnson & Johnson said its Covid-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant.

Jake Sargent, a spokesman for the New Brunswick, New Jersey company, confirmed an earlier report by health-care news provider STAT that the study was paused.

Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies in the US. The company has since begun dosing up to 60,000 volunteers, marking the first big trial of an Covid-19 inoculation that may work after just one shot.

Click here for complete coronavirus coverage

News of the halt comes after AstraZeneca Plc temporarily stopped tests of its vaccine after a trial participant fell ill. That study has resumed in a number of countries but remains halted in the US.

Get the latest World News, breaking headlines and global updates from the US, UK, Pakistan, Bangladesh, Russia and other countries. Follow major international events on Hindustan Times.